PROF · Profound Medical Corp.
$6.65
-0.43 (-6.07%)
At close · Aug 20
Market Cap
$258.65M
Shares
36.53M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-17 | — | |
| 8-K | 2026-08-17 | 2026-08-14 | |
| 8-K | 2026-08-13 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-07-24 | — | |
| 8-K | 2026-07-16 | — | |
| 8-K | 2026-07-15 | — | |
| 8-K | 2026-05-15 | 2026-05-13 | |
| 8-K | 2026-05-14 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| 8-K | 2026-04-16 | — | |
| 8-K | 2026-04-14 | — | |
| 8-K | 2026-04-01 | — | |
| 8-K | 2026-03-27 | — | |
| 8-K | 2026-03-13 | — | |
| 8-K | 2026-03-10 | 2026-03-05 | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2026-03-05 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-02-12 | — | |
| 8-K | 2026-02-12 | — | |
| 8-K | 2026-02-05 | — | |
| 8-K | 2026-01-28 | 2026-01-27 | |
| 8-K | 2026-01-15 | 2026-01-13 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-06 | — | |
| 8-K | 2025-12-31 | 2025-12-30 | |
| 8-K | 2025-12-19 | — | |
| 8-K | 2025-11-28 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-11-12 | 2025-11-11 | |
| 8-K | 2025-11-12 | 2025-11-10 | |
| 8-K | 2025-10-07 | — | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| Investor Event Transcript | 2025-06-30 | — | |
| 8-K | 2025-06-04 | — | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| 8-K | 2025-04-29 | — | |
| 8-K | 2025-04-29 | 2025-04-28 | |
| 8-K | 2025-04-22 | — | |
| 8-K | 2025-03-07 | 2025-03-03 | |
| 10-K | 2025-03-07 | 2024-12-31 | |
| 8-K | 2025-01-08 | — | |
| 6-K | 2025-01-06 | — |
Showing 1–50 of 193 filings
Key facts
CIK
1628808
CUSIP
74319B502
13F (30d)
55 filings
55 filers
Visit website
Investor relations